The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
00
Make vs Buy Business Analysis in Advanced Therapies
Make vs Buy Business Analysis in Advanced Therapies | In a moderated panel discussion, Project Farma details the considerations used in determining whether an advanced therapy company should manufacture therapies internally or utilize external third-party manufacturers. This discussion explores the rationale of gene and cell therapy companies using an external CMO or relying on internal manufacturing. With insight from one advanced therapy company that utilizes third party manufacturing, and another that manufactures internally, Project Farma provides the considerations for both cases along with perspective from a CMO regarding external manufacturing.
Speaker(s):
Tony
Khoury,
Vice President, Technical Services,
Project Farma